Detalhe da pesquisa
1.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
N Engl J Med
; 383(1): 35-48, 2020 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32579807
2.
Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).
Ann Allergy Asthma Immunol
; 118(4): 489-499.e1, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28256307
3.
Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways.
Clin Med (Lond)
; 15(2): 173-8, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25824071
4.
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6⯵g and 160/18/9.6⯵g using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.
Respir Med
; 158: 59-66, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31605923
5.
Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists.
J Clin Endocrinol Metab
; 100(3): E458-62, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25485725